Ensign Peak Advisors’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $460K | Hold |
26,893
| – | – | ﹤0.01% | 1579 |
|
|
2025
Q1 | $1.72M | Sell |
26,893
-146,598
| -84% | -$9.36M | ﹤0.01% | 965 |
|
|
2024
Q4 | $21.1M | Sell |
173,491
-51,837
| -23% | -$6.3M | 0.04% | 313 |
|
|
2024
Q3 | $28.1M | Hold |
225,328
| – | – | 0.05% | 265 |
|
|
2024
Q2 | $35.6M | Buy |
225,328
+38,090
| +20% | +$6.02M | 0.07% | 211 |
|
|
2024
Q1 | $24.2M | Sell |
187,238
-7,192
| -4% | -$931K | 0.04% | 289 |
|
|
2023
Q4 | $18.7M | Sell |
194,430
-3,215
| -2% | -$310K | 0.04% | 306 |
|
|
2023
Q3 | $24M | Sell |
197,645
-480
| -0.2% | -$58.2K | 0.05% | 252 |
|
|
2023
Q2 | $22.7M | Buy |
198,125
+10,780
| +6% | +$1.23M | 0.05% | 278 |
|
|
2023
Q1 | $25.8M | Buy |
187,345
+39,985
| +27% | +$5.51M | 0.06% | 252 |
|
|
2022
Q4 | $19.1M | Buy |
147,360
+16,750
| +13% | +$2.17M | 0.04% | 301 |
|
|
2022
Q3 | $14.4M | Buy |
130,610
+110,080
| +536% | +$12.2M | 0.04% | 314 |
|
|
2022
Q2 | $1.54M | Buy |
20,530
+400
| +2% | +$30K | ﹤0.01% | 920 |
|
|
2022
Q1 | $1.57M | Hold |
20,130
| – | – | ﹤0.01% | 977 |
|
|
2021
Q4 | $1.81M | Buy |
+20,130
| New | +$1.81M | ﹤0.01% | 999 |
|
|
2021
Q1 | – | Sell |
-22,766
| Closed | -$3.88M | – | 1879 |
|
|
2020
Q4 | $3.88M | Sell |
22,766
-6,748
| -23% | -$1.15M | 0.01% | 708 |
|
|
2020
Q3 | $4.14M | Buy |
29,514
+22,901
| +346% | +$3.22M | 0.01% | 682 |
|
|
2020
Q2 | $1.06M | Buy |
6,613
+4,957
| +299% | +$795K | ﹤0.01% | 1260 |
|
|
2020
Q1 | $162K | Sell |
1,656
-1,147
| -41% | -$112K | ﹤0.01% | 1552 |
|
|
2019
Q4 | $362K | Buy |
+2,803
| New | +$362K | ﹤0.01% | 1559 |
|